NASDAQ: ARCIUArchimedes Tech Spac Partners III Co Stock
$10.07-0.06 (-0.59%)
Updated Jan 26, 2026
ARCIU Price
$10.07
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$10.03
52 Week High
$10.14
P/E
-1,007x
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$69.52k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-5.09
Operating Cash Flow
$0
Beta
N/A
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ARCIU Overview
Archimedes Tech SPAC Partners III Co. is a blank-check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination, with a focus on technology-enabled businesses. The units generally consist of one Class A ordinary share and a fraction of a redeemable warrant, as described in the company’s offering documents.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ARCIU's potential to beat the market
- ARCIU doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
ARCIU
RankedUnranked of 30
RankedUnranked of 30
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $11.77 | C | |
| $10.65 | C | |
| $10.17 | C |
Be the first to know about important ARCIU news, forecast changes, insider trades & much more!
ARCIU News
Overview
Due Diligence Score
–
Industry Average (5)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ARCIU scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ARCIU is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ARCIU is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
ARCIU's Earnings (EBIT) of -$69.52k... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more ARCIU due diligence checks available for Premium users.
Valuation
ARCIU price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1,007x
Industry
11.64x
Market
41.46x
ARCIU's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
ARCIU's Earnings (EBIT) of -$69.52k... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$182.1k
Liabilities
$226.6k
Debt to equity
-5.09
ARCIU's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ARCIU's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
ARCIU's operating cash flow ($0.00)... subscribe to Premium to read more.
Debt Coverage Financials
ARCIU vs Shell Company Stocks
Archimedes Tech Spac Partners III Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.